These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 27775593)
1. Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression. Whiteside TL Vaccines (Basel); 2016 Oct; 4(4):. PubMed ID: 27775593 [TBL] [Abstract][Full Text] [Related]
2. Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression. Whiteside TL Adv Exp Med Biol; 2017; 1036():81-89. PubMed ID: 29275466 [TBL] [Abstract][Full Text] [Related]
3. Signaling of Tumor-Derived sEV Impacts Melanoma Progression. Zebrowska A; Widlak P; Whiteside T; Pietrowska M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709086 [TBL] [Abstract][Full Text] [Related]
4. Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology. Whiteside TL; Diergaarde B; Hong CS Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207762 [TBL] [Abstract][Full Text] [Related]
6. The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy. Whiteside TL Future Oncol; 2017 Dec; 13(28):2583-2592. PubMed ID: 29198150 [TBL] [Abstract][Full Text] [Related]
7. The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer. Czystowska-Kuzmicz M; Whiteside TL Expert Opin Biol Ther; 2021 Feb; 21(2):241-258. PubMed ID: 32813990 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of plasma exosomes in diagnosis, prognosis and therapies of patients with cancer. Whiteside TL Contemp Oncol (Pozn); 2018 Mar; 22(1A):38-40. PubMed ID: 29628792 [TBL] [Abstract][Full Text] [Related]
10. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Whiteside TL Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420 [TBL] [Abstract][Full Text] [Related]
11. The Role of Tumor-Derived Exosomes (TEX) in Shaping Anti-Tumor Immune Competence. Whiteside TL Cells; 2021 Nov; 10(11):. PubMed ID: 34831276 [TBL] [Abstract][Full Text] [Related]
12. Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence. Whiteside TL Expert Rev Mol Diagn; 2023 Feb; 23(2):109-122. PubMed ID: 36787282 [TBL] [Abstract][Full Text] [Related]
13. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer. Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274 [TBL] [Abstract][Full Text] [Related]
14. The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt? Kunigelis KE; Graner MW Vaccines (Basel); 2015 Dec; 3(4):1019-51. PubMed ID: 26694473 [TBL] [Abstract][Full Text] [Related]